BackAnavex Life Sciences Overview

Anavex Life Sciences Other Current Liabilities

Anavex Life Sciences's other current liabilities is $4M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$4.04M

Peer trimmed avg / median

Loading

Anavex Life Sciences Other Current Liabilities History

Loading

Anavex Life Sciences vs. peers: Other Current Liabilities Comparison

Loading

Anavex Life Sciences Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Anavex Life Sciences (AVXL) FAQ

Anavex Life Sciences (AVXL) currently reports a other current liabilities of $4M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Anavex Life Sciences's other current liabilities history and peer comparisons.

Anavex Life Sciences's other current liabilities changed from $0 to $4M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Anavex Life Sciences reported $4M in other current liabilities as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anavex Life Sciences, and consider following AVXL for alerts when major investors trade the stock.

Anavex Life Sciences is classified in the Healthcare sector. On other current liabilities, it currently shows $4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AVXL with unrelated industries.